Takeda set to swallow Shire
Shire’s US revenue and rare diseases portfolio grab Japanese firm’s attention
Japanese drug company Takeda Pharmaceutical is set to acquire Shire for £46 billion. The record-breaking deal is the largest overseas purchase by a Japanese company.